CAAS Capital Management’s Recursion Pharmaceuticals RXRX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-15,000	Closed	-$548K	–	768
2021 Q2	$548K	Buy	+15,000	New	+$548K	0.01%	401